Glaxo weighs Qualcomm JV in quest to move ‘beyond the pill’

Carly Helfand

Big Pharma companies–GlaxoSmithKline included–have been looking for ways to " the " to gain a technological leg up on their rivals. And now, the British drugmaker is reportedly weighing a move that could help it do just that.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS